Alkyl Amines Chemicals (ALKYLAMINE)₹1,618+2.00%Specialty Chemicals
In the Jun 2026 quarter (standalone), Alkyl Amines Chemicals reported sales of ₹528 Cr, up 30.1% from Jun 2025, and net profit of ₹95.29 Cr, up 93.8% year on year. For the year to Mar 2026, sales were ₹1,537 Cr and net profit ₹181 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 | 389 | 354 | 387 | 528 |
| Expenses | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 | 319 | 287 | 316 | 394 |
| Operating Profit | 48.13 | 60.20 | 69.28 | 79.23 | 74.31 | 71.24 | 68.25 | 77.29 | 70.24 | 67.20 | 71.21 | 134 |
| OPM % | 14.0% | 19.0% | 19.0% | 20.0% | 18.0% | 19.0% | 18.0% | 19.0% | 18.0% | 18.9% | 18.0% | 25.0% |
| Other Income | 1.99 | 4.99 | 2.99 | 4.98 | 8.97 | 6.98 | 8.98 | 7.98 | 6.98 | 7.98 | 7.97 | 8.98 |
| Interest | 1.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 12.96 | 16.95 | 16.94 | 17.95 | 17.93 | 17.95 | 17.94 | 17.93 | 17.93 | 17.96 | 17.95 | 17.94 |
| Profit before tax | 36.08 | 46.11 | 53.11 | 66.17 | 64.13 | 59.09 | 59.10 | 66.17 | 59.09 | 57.17 | 61.16 | 125 |
| Tax % | 24.9% | 27.9% | 27.9% | 25.9% | 25.9% | 25.9% | 21.9% | 24.9% | 27.0% | 26.0% | 24.9% | 24.0% |
| Net Profit | 27.08 | 33.11 | 38.11 | 49.20 | 47.19 | 44.18 | 46.13 | 49.17 | 43.16 | 42.17 | 45.16 | 95.29 |
| EPS (Rs) | 5.32 | 6.53 | 7.51 | 9.55 | 9.27 | 8.57 | 8.99 | 9.66 | 8.41 | 8.27 | 8.86 | 18.49 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 485 | 501 | 616 | 847 | 994 | 1,244 | 1,542 | 1,685 | 1,441 | 1,574 | 1,537 | 1,659 |
| Expenses | 393 | 405 | 499 | 682 | 737 | 812 | 1,217 | 1,336 | 1,190 | 1,281 | 1,251 | 1,316 |
| Operating Profit | 91.36 | 95.26 | 118 | 164 | 258 | 432 | 327 | 349 | 253 | 292 | 286 | 343 |
| OPM % | 19.0% | 18.9% | 18.9% | 19.0% | 25.9% | 35.0% | 21.0% | 21.0% | 17.0% | 19.0% | 19.0% | 20.7% |
| Other Income | 1.99 | 0.99 | 1.99 | 3.99 | 39.90 | 5.98 | 13.96 | 8.98 | 13.95 | 29.94 | 31.89 | 31.91 |
| Interest | 7.99 | 7.99 | 7.99 | 14.97 | 9.99 | 5.99 | 2.99 | 2.99 | 3.99 | 0.99 | 0.99 | 0.00 |
| Depreciation | 12.96 | 13.95 | 15.95 | 22.91 | 26.94 | 28.92 | 34.90 | 44.84 | 58.79 | 70.76 | 71.79 | 71.78 |
| Profit before tax | 72.18 | 74.11 | 96.17 | 130 | 260 | 402 | 303 | 310 | 202 | 249 | 244 | 303 |
| Tax % | 30.9% | 32.0% | 32.9% | 35.9% | 17.0% | 25.9% | 25.9% | 25.9% | 25.9% | 24.9% | 25.9% | — |
| Exceptional items | 0.00 | 0.00 | −0.99 | 0.00 | 25.93 | −0.99 | 0.00 | −2.99 | −0.99 | 0.00 | 0.00 | — |
| Net Profit | 50.14 | 50.18 | 64.24 | 84.25 | 216 | 296 | 226 | 230 | 149 | 187 | 181 | 226 |
| EPS (Rs) | 9.76 | 9.86 | 12.60 | 16.43 | 42.18 | 57.87 | 44.03 | 44.73 | 29.11 | 36.38 | 35.18 | 44.03 |
| Dividend payout % | 41.0% | 20.0% | 22.0% | 20.0% | 19.0% | 17.0% | 23.0% | 22.0% | 34.0% | 28.0% | 28.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.97 | 9.96 | 9.96 | 9.97 | 9.97 | 9.97 | 9.96 | 9.97 | 9.96 | 9.97 | 9.96 | 9.97 |
| Reserves | 165 | 189 | 235 | 287 | 355 | 527 | 783 | 982 | 1,161 | 1,259 | 1,393 | 1,525 |
| Borrowings | 135 | 111 | 120 | 181 | 165 | 87.15 | 47.08 | 23.04 | 88.25 | 3.01 | 6.02 | 1.01 |
| Other Liabilities | 92.55 | 94.54 | 146 | 159 | 218 | 160 | 305 | 357 | 333 | 314 | 381 | 361 |
| Total Liabilities | 402 | 406 | 512 | 638 | 749 | 784 | 1,145 | 1,371 | 1,593 | 1,587 | 1,791 | 1,897 |
| Fixed Assets | 152 | 188 | 221 | 357 | 377 | 425 | 460 | 631 | 722 | 1,093 | 1,048 | 1,018 |
| CWIP | 30.94 | 15.97 | 34.94 | 17.99 | 42.91 | 44.94 | 138 | 143 | 351 | 35.93 | 51.95 | 130 |
| Investments | 1.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.00 | 29.89 | 0.00 | 0.00 | 0.00 | 0.00 | 50.84 |
| Other Assets | 217 | 200 | 255 | 261 | 327 | 314 | 518 | 598 | 519 | 458 | 690 | 698 |
| Inventories | 71.24 | 63.23 | 111 | 85.33 | 106 | 84.23 | 122 | 166 | 185 | 173 | 166 | 123 |
| Trade receivables | 99.25 | 90.24 | 97.17 | 124 | 153 | 164 | 229 | 278 | 258 | 222 | 231 | 231 |
| Cash & equivalents | 7.98 | 3.99 | 2.99 | 2.99 | 19.97 | 31.92 | 126 | 62.85 | 17.97 | 30.94 | 203 | 202 |
| Total Assets | 402 | 406 | 512 | 638 | 749 | 784 | 1,145 | 1,371 | 1,593 | 1,587 | 1,791 | 1,897 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 60.73 | 101 | 62.76 | 102 | 143 | 187 | 363 | 204 | 247 | 274 | 262 | 238 |
| Cash from investing activity | −31.11 | −35.12 | −65.20 | −132 | −67.20 | −41.13 | −214 | −207 | −278 | −121 | −197 | −137 |
| Cash from financing activity | −35.99 | −68.06 | −1.99 | 31.98 | −59.97 | −135 | −85.99 | −56.97 | 8.01 | −140 | −49.02 | −55.99 |
| Net cash flow | −6.01 | −2.01 | −3.01 | 2.01 | 17.02 | 12.02 | 65.11 | −58.05 | −21.03 | 13.01 | 18.02 | 45.02 |
| Capex | 41.05 | 35.05 | 66.16 | 136 | 69.08 | 77.10 | 156 | 247 | 303 | 122 | 48.09 | 128 |
| Free cash flow | 19.99 | 66.05 | −1.01 | −33.02 | 75.09 | 111 | 208 | −41.03 | −55.01 | 153 | 216 | 111 |
| CFO / OP % | 95.1% | 128.1% | 88.1% | 103.1% | 109.0% | 96.1% | 108.0% | 86.1% | 92.0% | 123.1% | 108.1% | 101.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 | 55 |
| Inventory days | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 | 57 |
| Days payable | 59 | 64 | 121 | 79 | 105 | 58 | 134 | 106 | 85 | 86 | 81 | 71 |
| Cash conversion cycle | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 | 42 |
| Working capital days | 94 | 88 | 85 | 77 | 57 | 55 | 27 | 36 | 29 | 48 | 43 | 50 |
| ROCE % | 26.0% | 26.0% | 24.0% | 25.0% | 29.0% | 41.0% | 56.0% | 33.0% | 28.0% | 16.0% | 19.0% | 17.0% |
For the Jun 2026 quarter, Alkyl Amines Chemicals reported sales of ₹528 Cr, up 30.1% year on year and net profit of ₹95.29 Cr, up 93.8% year on year. The operating margin was 25.0%.
Alkyl Amines Chemicals' sales for the year to Mar 2026 were ₹1,537 Cr; over the last twelve months they were ₹1,659 Cr.
Net profit for the year to Mar 2026 was ₹181 Cr, and ₹226 Cr over the last twelve months. Earnings per share over the same trailing period were ₹44.03.
Alkyl Amines Chemicals reported borrowings of ₹1.01 Cr at Mar 2026, against cash and equivalents of ₹202 Cr.
Cash from operations was ₹238 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹111 Cr.